Publications:

Phase and context shape the function of composite oncogenic mutations.

Nature

Gorelick, Alexander N AN; Sánchez-Rivera, Francisco J FJ; Cai, Yanyan Y; Bielski, Craig M CM; Biederstedt, Evan E; Jonsson, Philip P; Richards, Allison L AL; Vasan, Neil N; Penson, Alexander V AV; Friedman, Noah D ND; Ho, Yu-Jui YJ; Baslan, Timour T; Bandlamudi, Chaitanya C; Scaltriti, Maurizio M; Schultz, Nikolaus N; Lowe, Scott W SW; Reznik, Ed E; Taylor, Barry S BS

Publication Date: 2020-06

Variant appearance in text: PTEN: R130del

PubMed Link: 32461694

Variant Present in the following documents:

• NIHMS1582596-supplement-1582596_Supp_Tab1-5.xlsx, sheet 2

View BVdb publication page

SETD2 mutations in primary central nervous system tumors.

Acta Neuropathologica Communications

Viaene, Angela N AN; Santi, Mariarita M; Rosenbaum, Jason J; Li, Marilyn M MM; Surrey, Lea F LF; Nasrallah, MacLean P MP

Publication Date: 2018-11-12

Variant appearance in text: PTEN: R130del

PubMed Link: 30419952

Variant Present in the following documents:

• Main text
• 40478_2018_Article_623.pdf

View BVdb publication page

PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells.

Oncotarget

Phadngam, Suratchanee S; Castiglioni, Andrea A; Ferraresi, Alessandra A; Morani, Federica F; Follo, Carlo C; Isidoro, Ciro C

Publication Date: 2016-12-20

Variant appearance in text: PTEN: R130del

PubMed Link: 27829222

Variant Present in the following documents:

• Main text
• oncotarget-07-84999.pdf

View BVdb publication page